These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35782147)

  • 1. Expanding the Malaria Antibody Toolkit: Development and Characterisation of
    Nacer A; Kivi G; Pert R; Juronen E; Holenya P; Aliprandini E; Amino R; Silvie O; Quinkert D; Le Duff Y; Hurley M; Reimer U; Tover A; Draper SJ; Gilbert S; Ho MM; Bowyer PW
    Front Cell Infect Microbiol; 2022; 12():901253. PubMed ID: 35782147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strain-Dependent Inhibition of Erythrocyte Invasion by Monoclonal Antibodies Against
    Knudsen AS; Björnsson KH; Bassi MR; Walker MR; Kok A; Cristinoi B; Jensen AR; Barfod L
    Front Immunol; 2021; 12():716305. PubMed ID: 34447381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of Plasmodium falciparum parasite-inhibitory antibodies by immunization with recombinantly-expressed CyRPA.
    Favuzza P; Blaser S; Dreyer AM; Riccio G; Tamborrini M; Thoma R; Matile H; Pluschke G
    Malar J; 2016 Mar; 15():161. PubMed ID: 26979066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterially expressed full-length recombinant Plasmodium falciparum RH5 protein binds erythrocytes and elicits potent strain-transcending parasite-neutralizing antibodies.
    Reddy KS; Pandey AK; Singh H; Sahar T; Emmanuel A; Chitnis CE; Chauhan VS; Gaur D
    Infect Immun; 2014 Jan; 82(1):152-64. PubMed ID: 24126527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmodium falciparum Cysteine-Rich Protective Antigen (CyRPA) Elicits Detectable Levels of Invasion-Inhibitory Antibodies during Natural Infection in Humans.
    Mian SY; Somanathan A; Chaddha K; Pandey AK; Singh H; Krishna S; Chaturvedi N; Uchoi S; Shukla MM; Bharti PK; Singh N; Chauhan VS; Gaur D
    Infect Immun; 2022 Jan; 90(1):e0037721. PubMed ID: 34694918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing neutralization of Plasmodium falciparum using a novel monoclonal antibody against the rhoptry-associated membrane antigen.
    Knudsen AS; Walker MR; Agullet JP; Björnsson KH; Bassi MR; Barfod L
    Sci Rep; 2022 Feb; 12(1):3040. PubMed ID: 35197516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dual action of human antibodies specific to Plasmodium falciparum PfRH5 and PfCyRPA: Blocking invasion and inactivating extracellular merozoites.
    Weiss GE; Ragotte RJ; Quinkert D; Lias AM; Dans MG; Boulet C; Looker O; Ventura OD; Williams BG; Crabb BS; Draper SJ; Gilson PR
    PLoS Pathog; 2023 Sep; 19(9):e1011182. PubMed ID: 37713419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A malaria vaccine candidate based on an epitope of the Plasmodium falciparum RH5 protein.
    Ord RL; Caldeira JC; Rodriguez M; Noe A; Chackerian B; Peabody DS; Gutierrez G; Lobo CA
    Malar J; 2014 Aug; 13():326. PubMed ID: 25135070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiprotein complex between the GPI-anchored CyRPA with PfRH5 and PfRipr is crucial for Plasmodium falciparum erythrocyte invasion.
    Reddy KS; Amlabu E; Pandey AK; Mitra P; Chauhan VS; Gaur D
    Proc Natl Acad Sci U S A; 2015 Jan; 112(4):1179-84. PubMed ID: 25583518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralising antibodies block the function of Rh5/Ripr/CyRPA complex during invasion of Plasmodium falciparum into human erythrocytes.
    Healer J; Wong W; Thompson JK; He W; Birkinshaw RW; Miura K; Long CA; Soroka V; Søgaard TMM; Jørgensen T; de Jongh WA; Weir C; Svahn E; Czabotar PE; Tham WH; Mueller I; Barlow PN; Cowman AF
    Cell Microbiol; 2019 Jul; 21(7):e13030. PubMed ID: 30965383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The RH5-CyRPA-Ripr Complex as a Malaria Vaccine Target.
    Ragotte RJ; Higgins MK; Draper SJ
    Trends Parasitol; 2020 Jun; 36(6):545-559. PubMed ID: 32359873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Process development and preclinical evaluation of a major
    Somanathan A; Mian SY; Chaddha K; Uchoi S; Bharti PK; Tandon R; Gaur D; Chauhan VS
    Front Immunol; 2022; 13():1005332. PubMed ID: 36211427
    [No Abstract]   [Full Text] [Related]  

  • 13. The Structure of the Cysteine-Rich Domain of Plasmodium falciparum P113 Identifies the Location of the RH5 Binding Site.
    Campeotto I; Galaway F; Mehmood S; Barfod LK; Quinkert D; Kotraiah V; Phares TW; Wright KE; Snijders AP; Draper SJ; Higgins MK; Wright GJ
    mBio; 2020 Sep; 11(5):. PubMed ID: 32900802
    [No Abstract]   [Full Text] [Related]  

  • 14. Naturally acquired antibodies specific for Plasmodium falciparum reticulocyte-binding protein homologue 5 inhibit parasite growth and predict protection from malaria.
    Tran TM; Ongoiba A; Coursen J; Crosnier C; Diouf A; Huang CY; Li S; Doumbo S; Doumtabe D; Kone Y; Bathily A; Dia S; Niangaly M; Dara C; Sangala J; Miller LH; Doumbo OK; Kayentao K; Long CA; Miura K; Wright GJ; Traore B; Crompton PD
    J Infect Dis; 2014 Mar; 209(5):789-98. PubMed ID: 24133188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of the malaria vaccine candidate antigen CyRPA and its complex with a parasite invasion inhibitory antibody.
    Favuzza P; Guffart E; Tamborrini M; Scherer B; Dreyer AM; Rufer AC; Erny J; Hoernschemeyer J; Thoma R; Schmid G; Gsell B; Lamelas A; Benz J; Joseph C; Matile H; Pluschke G; Rudolph MG
    Elife; 2017 Feb; 6():. PubMed ID: 28195038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccines and monoclonal antibodies: new tools for malaria control.
    Miura K; Flores-Garcia Y; Long CA; Zavala F
    Clin Microbiol Rev; 2024 Jun; 37(2):e0007123. PubMed ID: 38656211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limited genetic variations of the Rh5-CyRPA-Ripr invasion complex in
    Waweru H; Kanoi BN; Kuja JO; Maranga M; Kongere J; Maina M; Kinyua J; Gitaka J
    Front Trop Dis; 2023 Mar; 4():1102265. PubMed ID: 38406638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphisms in malaria vaccine candidate Plasmodium falciparum reticulocyte-binding protein homologue-5 among populations in Lagos, Nigeria.
    Ajibaye O; Osuntoki AA; Balogun EO; Olukosi YA; Iwalokun BA; Oyebola KM; Hikosaka K; Watanabe YI; Ebiloma GU; Kita K; Amambua-Ngwa A
    Malar J; 2020 Jan; 19(1):6. PubMed ID: 31906953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex.
    Williams BG; King LDW; Pulido D; Quinkert D; Lias AM; Silk SE; Ragotte RJ; Davies H; Barrett JR; McHugh K; Rigby CA; Alanine DGW; Barfod L; Shea MW; Cowley LA; Dabbs RA; Pattinson DJ; Douglas AD; Lyth OR; Illingworth JJ; Jin J; Carnrot C; Kotraiah V; Christen JM; Noe AR; MacGill RS; King CR; Birkett AJ; Soisson LA; Skinner K; Miura K; Long CA; Higgins MK; Draper SJ
    Nat Commun; 2024 Jun; 15(1):4857. PubMed ID: 38849365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Essential Role of the PfRh5/PfRipr/CyRPA Complex during Plasmodium falciparum Invasion of Erythrocytes.
    Volz JC; Yap A; Sisquella X; Thompson JK; Lim NT; Whitehead LW; Chen L; Lampe M; Tham WH; Wilson D; Nebl T; Marapana D; Triglia T; Wong W; Rogers KL; Cowman AF
    Cell Host Microbe; 2016 Jul; 20(1):60-71. PubMed ID: 27374406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.